Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Possible associations of NTRK2 polymorphisms with antidepressant treatment outcome: findings from an extended tag SNP approach.

Hennings JM, Kohli MA, Czamara D, Giese M, Eckert A, Wolf C, Heck A, Domschke K, Arolt V, Baune BT, Horstmann S, Brückl T, Klengel T, Menke A, Müller-Myhsok B, Ising M, Uhr M, Lucae S.

PLoS One. 2013 Jun 4;8(6):e64947. doi: 10.1371/journal.pone.0064947. Print 2013.

2.

Association of genetic variants in the neurotrophic receptor-encoding gene NTRK2 and a lifetime history of suicide attempts in depressed patients.

Kohli MA, Salyakina D, Pfennig A, Lucae S, Horstmann S, Menke A, Kloiber S, Hennings J, Bradley BB, Ressler KJ, Uhr M, Müller-Myhsok B, Holsboer F, Binder EB.

Arch Gen Psychiatry. 2010 Apr;67(4):348-59. doi: 10.1001/archgenpsychiatry.2009.201. Epub 2010 Feb 1.

3.

Gene-gene interactions of the brain-derived neurotrophic-factor and neurotrophic tyrosine kinase receptor 2 genes in geriatric depression.

Lin E, Hong CJ, Hwang JP, Liou YJ, Yang CH, Cheng D, Tsai SJ.

Rejuvenation Res. 2009 Dec;12(6):387-93. doi: 10.1089/rej.2009.0871.

PMID:
20014955
4.
5.

Neurotrophin Genes and Antidepressant-Worsening Suicidal Ideation: A Prospective Case-Control Study.

Voegeli G, Ramoz N, Shekhtman T, Courtet P, Gorwood P, Kelsoe JR.

Int J Neuropsychopharmacol. 2016 Dec 3;19(11). pii: pyw059. doi: 10.1093/ijnp/pyw059. Print 2016 Nov.

6.

Extensive genotyping of the BDNF and NTRK2 genes define protective haplotypes against obsessive-compulsive disorder.

Alonso P, Gratacòs M, Menchón JM, Saiz-Ruiz J, Segalàs C, Baca-García E, Labad J, Fernández-Piqueras J, Real E, Vaquero C, Pérez M, Dolengevich H, González JR, Bayés M, de Cid R, Vallejo J, Estivill X.

Biol Psychiatry. 2008 Mar 15;63(6):619-28. Epub 2007 Sep 19.

PMID:
17884018
7.

Increased BDNF levels and NTRK2 gene association suggest a disruption of BDNF/TrkB signaling in autism.

Correia CT, Coutinho AM, Sequeira AF, Sousa IG, Lourenço Venda L, Almeida JP, Abreu RL, Lobo C, Miguel TS, Conroy J, Cochrane L, Gallagher L, Gill M, Ennis S, Oliveira GG, Vicente AM.

Genes Brain Behav. 2010 Oct;9(7):841-8. doi: 10.1111/j.1601-183X.2010.00627.x. Epub 2010 Aug 19.

8.

Genetic predictors of increase in suicidal ideation during antidepressant treatment in the GENDEP project.

Perroud N, Aitchison KJ, Uher R, Smith R, Huezo-Diaz P, Marusic A, Maier W, Mors O, Placentino A, Henigsberg N, Rietschel M, Hauser J, Souery D, Kapelski P, Bonvicini C, Zobel A, Jorgensen L, Petrovic A, Kalember P, Schulze TG, Gupta B, Gray J, Lewis CM, Farmer AE, McGuffin P, Craig I.

Neuropsychopharmacology. 2009 Nov;34(12):2517-28. doi: 10.1038/npp.2009.81. Epub 2009 Jul 29.

9.

The interaction of BDNF and NTRK2 gene increases the susceptibility of paranoid schizophrenia.

Lin Z, Su Y, Zhang C, Xing M, Ding W, Liao L, Guan Y, Li Z, Cui D.

PLoS One. 2013 Sep 17;8(9):e74264. doi: 10.1371/journal.pone.0074264. eCollection 2013.

10.

Novel sequence variations in the brain-derived neurotrophic factor gene and association with major depression and antidepressant treatment response.

Licinio J, Dong C, Wong ML.

Arch Gen Psychiatry. 2009 May;66(5):488-97. doi: 10.1001/archgenpsychiatry.2009.38.

11.

Gene-gene interactions among CHRNA4, CHRNB2, BDNF, and NTRK2 in nicotine dependence.

Li MD, Lou XY, Chen G, Ma JZ, Elston RC.

Biol Psychiatry. 2008 Dec 1;64(11):951-7. doi: 10.1016/j.biopsych.2008.04.026. Epub 2008 Jun 4.

12.

Association studies of the BDNF and the NTRK2 gene polymorphisms with prophylactic lithium response in bipolar patients.

Dmitrzak-Weglarz M, Rybakowski JK, Suwalska A, Skibinska M, Leszczynska-Rodziewicz A, Szczepankiewicz A, Hauser J.

Pharmacogenomics. 2008 Nov;9(11):1595-603. doi: 10.2217/14622416.9.11.1595.

PMID:
19018715
13.

Genetic association of neurotrophic tyrosine kinase receptor type 2 (NTRK2) With Alzheimer's disease.

Chen Z, Simmons MS, Perry RT, Wiener HW, Harrell LE, Go RC.

Am J Med Genet B Neuropsychiatr Genet. 2008 Apr 5;147(3):363-9.

PMID:
17918233
14.

No impact of eight NTRK2 genetic polymorphisms on 6-month antidepressant efficacy in depressed patients.

Deflesselle E, Verstuyft C, Petit AC, Hardy P, David DJ, Falissard B, Fève B, Rigal L, Becquemont L, Corruble E, Colle R.

Pharmacogenomics. 2017 Mar;18(4):349-357. doi: 10.2217/pgs-2016-0165. Epub 2017 Feb 17.

PMID:
28244805
15.

BDNF/TRKB/P75NTR polymorphisms and their consequences on antidepressant efficacy in depressed patients.

Colle R, Deflesselle E, Martin S, David DJ, Hardy P, Taranu A, Falissard B, Verstuyft C, Corruble E.

Pharmacogenomics. 2015;16(9):997-1013. doi: 10.2217/pgs.15.56. Epub 2015 Jun 30. Review.

PMID:
26122862
16.

BDNF and CREB1 genetic variants interact to affect antidepressant treatment outcomes in geriatric depression.

Murphy GM Jr, Sarginson JE, Ryan HS, O'Hara R, Schatzberg AF, Lazzeroni LC.

Pharmacogenet Genomics. 2013 Jun;23(6):301-13. doi: 10.1097/FPC.0b013e328360b175.

PMID:
23619509
17.

Brain-derived neurotrophic factor gene polymorphisms: influence on treatment response phenotypes of major depressive disorder.

Kocabas NA, Antonijevic I, Faghel C, Forray C, Kasper S, Lecrubier Y, Linotte S, Massat I, Mendlewicz J, Noro M, Montgomery S, Oswald P, Snyder L, Zohar J, Souery D.

Int Clin Psychopharmacol. 2011 Jan;26(1):1-10.

PMID:
21188787
18.

Investigating the associations between polymorphisms in the NTRK2 and NGFR genes and completed suicide in the Slovenian sample.

Ropret S, Zupanc T, Komel R, Videtič Paska A.

Psychiatr Genet. 2015 Dec;25(6):241-8. doi: 10.1097/YPG.0000000000000109.

PMID:
26462037
19.

Polymorphisms in GRIK4, HTR2A, and FKBP5 show interactive effects in predicting remission to antidepressant treatment.

Horstmann S, Lucae S, Menke A, Hennings JM, Ising M, Roeske D, Müller-Myhsok B, Holsboer F, Binder EB.

Neuropsychopharmacology. 2010 Feb;35(3):727-40. doi: 10.1038/npp.2009.180. Epub 2009 Nov 18.

20.

Association study of neurotrophic tyrosine kinase receptor type 2 (NTRK2) and childhood-onset mood disorders.

Adams JH, Wigg KG, King N, Burcescu I, Vetró A, Kiss E, Baji I, George CJ, Kennedy JL, Kovacs M, Barr CL.

Am J Med Genet B Neuropsychiatr Genet. 2005 Jan 5;132B(1):90-5.

PMID:
15389758

Supplemental Content

Support Center